| Urinary System Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived193 of 193show fewer |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 183 trials (92 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 183 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 141 trials (63 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 141 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 114 trials (10 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 87 trials (45 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 76 trials (42 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 62 trials (34 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 60 trials (6 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 59 trials (22 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 55 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 53 trials (30 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 53 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 49 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 47 trials (15 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 42 trials (11 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 33 trials (29 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 32 trials (16 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 30 trials (15 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 29 trials (15 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 28 trials (8 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 25 trials (21 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 24 trials (19 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 22 trials (6 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 22 trials (13 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 22 trials (11 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 21 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 12 trials (9 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 12 trials (7 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 11 trials (5 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 10 trials (9 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nadofaragene Firadenovecgene therapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bacillus Calmette-Guerin BCG 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alpha-2a 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 5-Aminolevulinic Acid 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD-1 Monoclonal Antibody MEDI0680 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apitolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumab/Tremelimumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Foretinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfacon-1other 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nogapendekin Alfa Inbakiceptother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2aother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rogaratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tandutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tyrosine Kinase Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valrubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zenocutuzumab-zbcomonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Urinary System Carcinoma | 1 | Observed | clinicaltrials | graph → |